The global peripheral interventions market size was evaluated at USD 9.51 billion by 2023 and is projected to gain around USD 22.57 billion by 2033 with a CAGR of 9.03% between 2024 and 2033.
Key Points
- The North America peripheral interventions market size is exhibited at USD 3.42 billion in 2023 and is expected to attain around USD 8.24 billion by 2033, poised to grow at a CAGR of 9.19% between 2024 and 2033.
- North America dominated the market with the largest revenue share of 36% in 2023.
- Asia- Pacific is the fastest growing in the peripheral interventions market during the forecast period.
- By type, the catheters segment dominated the market in 2023.
- By type, the stents segment shows a notable growth in the peripheral interventions market during the forecast period.
- By application, the peripheral artery disease segment dominated the market in 2023.
- By application, the venous thromboembolism segment is the fastest growing in the peripheral interventions market during the forecast period.
- By end- user, the hospitals segment dominated the peripheral interventions market.
- By end- user, the ambulatory surgical centers segment shows a significant growth in the peripheral interventions market during the forecast period.
Get the Sample Copy of This Report@ https://www.precedenceresearch.com/sample/4463
Market Overview
The peripheral interventions market encompasses a range of minimally invasive procedures and devices used to treat peripheral artery disease (PAD) and other vascular conditions affecting the peripheral arteries, veins, and lymphatic systems. This market includes angioplasty balloons, stents, atherectomy devices, embolic protection devices, and chronic total occlusion (CTO) devices, among others. These interventions are designed to restore blood flow, reduce symptoms, and improve the quality of life for patients suffering from various vascular diseases. The market has seen substantial growth due to advancements in technology, increasing prevalence of PAD, and rising demand for minimally invasive surgical procedures.
Growth Factors
Several factors contribute to the growth of the peripheral interventions market. The rising incidence of peripheral artery disease, largely driven by the global increase in diabetes and obesity rates, is a significant driver. Advances in medical technology, such as the development of drug-eluting stents and bioresorbable scaffolds, enhance treatment efficacy and patient outcomes, further propelling market growth. Additionally, an aging population, which is more susceptible to vascular diseases, also fuels demand for peripheral interventions. Increased awareness about PAD and improved diagnostic techniques have led to earlier detection and treatment, contributing to the market’s expansion.
Peripheral Interventions Market Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 9.51 Billion |
| Market Size in 2024 | USD 10.37 Billion |
| Market Size by 2033 | USD 22.57 Billion |
| Market Growth Rate from 2024 to 2033 | CAGR of 9.03% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product, Application, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Dynamics
Drivers
Key drivers of the peripheral interventions market include technological innovations and the growing preference for minimally invasive procedures. Innovations such as next-generation stents, atherectomy devices, and imaging technologies improve the safety and effectiveness of treatments, making them more appealing to both physicians and patients. Additionally, the shift towards outpatient settings and ambulatory surgical centers, driven by cost-effectiveness and patient convenience, supports market growth. Reimbursement policies and government initiatives aimed at improving vascular health also play a crucial role in driving the market.
Opportunities
The peripheral interventions market presents several opportunities for growth. Emerging markets in Asia-Pacific and Latin America offer significant potential due to improving healthcare infrastructure, increasing healthcare expenditure, and a growing patient population. The development of novel devices and technologies, such as bioresorbable stents and advanced drug-coated balloons, provides opportunities for companies to differentiate their products and capture market share. Additionally, expanding applications of peripheral interventions beyond traditional indications, such as in the treatment of venous diseases and lymphatic disorders, present new growth avenues.
Challenges
Despite its growth prospects, the peripheral interventions market faces several challenges. High costs associated with advanced devices and procedures can limit accessibility, particularly in developing regions. Regulatory hurdles and stringent approval processes can delay the introduction of new products to the market. Additionally, the risk of complications and restenosis associated with some peripheral interventions remains a concern, necessitating ongoing research and development to improve device safety and efficacy. Competition from alternative treatments and therapies also poses a challenge to market growth.
Region Insights
North America holds a significant share of the peripheral interventions market, driven by high healthcare spending, advanced medical infrastructure, and a large patient pool. Europe follows, benefiting from well-established healthcare systems and increasing adoption of minimally invasive procedures. The Asia-Pacific region is expected to witness the fastest growth, attributed to rising healthcare investments, improving access to healthcare services, and increasing awareness of PAD. Countries such as China and India, with their large populations and growing healthcare needs, are key markets in this region. Latin America and the Middle East & Africa also offer growth opportunities, albeit at a slower pace, due to improving healthcare infrastructure and increasing incidence of vascular diseases.
Read Also: https://www.businesswebwire.com/age-related-macular-degeneration-treatment-market/
Peripheral Interventions Market Companies
- Biotronik SE & Co. KG
- Teleflex Incorporated
- Abbott Laboratories
- Boston Scientific Corporation
- Cook Medical
- W. L. Gore & Associates Inc
- Cardinal Health Inc
- Angio Dynamics Inc
- Medtronic
- B. Braun Melsungen AG
- Terumo Corporation
- Becton Dickinson and Company
Recent Developments
- In February 2024, the next-generation intermediate catheter with TruCourse, CEREGLIDE 71 Intermediate Catheter, has been launched by CERENOVUS, Inc., a Johnson & Johnson MedTech division. It is intended for the revascularization of individuals experiencing acute ischemic stroke.
- In June 2023, Blue Medical Devices, a Wellinq group company headquartered in Helmond, the Netherlands, has been acquired by Translumina, a leader in the global market for interventional cardiovascular medical devices with manufacturing facilities in Germany and India. The company was founded in 2013 and manufactures a cutting-edge assortment of balloon catheters, such as Drug-Coated Balloons (DCB) and other specialty balloons for intricate cardiac procedures.
Segments Covered in the Report
By Product
- Catheters
- Sheath
- Stents
- Bare Metal Stents
- Drug-eluting Stents
- Guide Wires
- Atherectomy Devices
- Embolic Devices
- IVC Filters
By Application
- Peripheral Artery Disease
- Venous Thromboembolism
- Others
By End-use
- Hospitals
- Catheterization Laboratories
- Ambulatory Surgical Centers
- Others
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.dailystatsnews.com/